Overview

Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin

Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if prazosin is more effective than placebo in decreasing frequency, severity, disability, and other negative effects of headaches related to mild traumatic brain injury in Service Members and Veterans.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Prazosin